HOME
HIV and AIDS
Hepatitis B
Hepatitis C
HIV-HCV Coinfection
HIV-HBV Coinfection
HIV and AIDS Articles
  FDA-approved Treatments
 
Experimental Treatments
 
Top New Articles
  Guidelines
HOME PAGE

International AIDS Conference Begins Sunday in Mexico City

The XVII International AIDS Conference (IAC 2008) will take place next week, August 3-8, at Centro Banamex in Mexico City -- the first time the conference is being held in Latin America. As the oldest and largest conference addressing HIV/AIDS, IAC 2008 -- with the theme "Universal Action Now" -- will feature sessions on a wide range of aspects of the global epidemic.

This International AIDS Conference is convened every other summer by the International AIDS Society (IAS), with the IAS Conference on HIV Pathogenesis, Treatment and Prevention taking place in alternate years. Although the IAC is more focused on social, cultural, economic, and policy issues related to the epidemic, the meeting will feature numerous sessions each day devoted to biomedical prevention technologies, advances in antiretroviral therapy, and management of side effects and associated conditions.

Upwards of 25,000 people are expected to participate in the conference. World leaders scheduled to attend include Mexican President Felipe Calderon Hinojosa, United Nations Secretary General Ban Ki-moon, and former U.S. President Bill Clinton.

HIV and Hepatitis.com will report on the most interesting epidemiology, prevention, and treatment presentations beginning on August 5 and continuing for the next several issues. In addition, we will also feature a selection of coverage from the Kaiser Family Foundation, as well as daily CME expert podcasts discussing highlights from the medical presentations.

Further information, including the full conference program and abstracts (viewable starting at the time of presentation), is available at www.aids2008.org.

8/01/08

Source
XVII International AIDS Conference.


 

 

 

 

 

 

 

Protease Inhibitors
Agenerase (amprenavir)
Aptivus (tipranavir)
Crixivan (indinavir)
Invirase (saquinavir hard gel)
Kaletra (lopinavir/ritonavir)
Lexiva (fosamprenavir)
Norvir (ritonavir)
Prezista (darunavir)
Reyataz (atazanavir)
Viracept (nelfinavir)
Nucleoside / Nucleotide Reverse Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry ( maraviroc)
Fixed-dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)